<SEC-DOCUMENT>0000920465-20-000165-index.html : 20201214 <SEC-HEADER>0000920465-20-000165.hdr.sgml : 20201214 <ACCEPTANCE-DATETIME>20201214162341 ACCESSION NUMBER: 0000920465-20-000165 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201210 FILED AS OF DATE: 20201214 DATE AS OF CHANGE: 20201214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Edwards Larry G. CENTRAL INDEX KEY: 0001733062 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 201386438 MAIL ADDRESS: STREET 1: C/O TETRAPHASE PHARMACEUTICALS, INC. STREET 2: 480 ARSENAL STREET, SUITE 110 CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE, SUITE 240 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE, SUITE 240 CITY: SAN DIEGO STATE: CA ZIP: 92121 </SEC-HEADER> <DOCUMENT> <TYPE>4 <SEQUENCE>1 <FILENAME>wf-form4_160798100779641.xml <DESCRIPTION>FORM 4 <TEXT> Document 1 - file: wf-form4_160798100779641.html
Document 1 - RAW XML: wf-form4_160798100779641.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-24 <SEQUENCE>2 <FILENAME>larryedwardsljpcpoa.htm <DESCRIPTION>POA <TEXT> Document 2 - file: larryedwardsljpcpoa.htm
</DOCUMENT> </SEC-DOCUMENT>